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An Aspergillus fumigatus vaccine based on recombinant Asp f3-protein has the potential
to prevent aspergillosis in humans, a devastating fungal disease that is the prime obsta-
cle to the success of hematopoietic cell transplantation. This vaccine protects cortisone
acetate (CA)-immunosuppressed mice from invasive pulmonary aspergillosis via CD4+ T
cell mediators. Aside from these mediators, the nature of downstream fungicidal effec-
tors is not well understood. Neutrophils and macrophages protect immunocompetent
individuals from invasive fungal infections, and selective neutrophil depletion rendered
mice susceptible to aspergillosis whereas macrophage depletion failed to increase fun-
gal susceptibility. We investigated the effect of neutrophil depletion on rAsp f3-vaccine
protection, and explored differences in pathophysiology and susceptibility between CA-
immunosuppression and neutrophil depletion. In addition to being protective under CA-
immunosuppression, the vaccine also had a protective effect in neutrophil-depleted mice.
However, in non-immunized mice, a 10-fold higher conidial dose was required to induce sim-
ilar susceptibility to infection with neutrophil depletion than with CA-immunosuppression.
The lungs of non-immunized neutrophil-depleted mice became invaded by a patchy dense
mycelium with highly branched hyphae, and the peribronchial inflammatory infiltrate con-
sisted mainly of CD3+ T cells and largely lacked macrophages. In contrast, lungs of non-
immunized CA-immunosuppressed mice were more evenly scattered with short hyphal
elements. With rAsp f3-vaccination, the lungs were largely clear of fungal burden under
either immunosuppressive condition.We conclude that neutrophils, although important for
innate antifungal protection of immunocompetent hosts, are not the relevant effectors for
rAsp f3-vaccine derived protection of immunosuppressed hosts. It is therefore more likely
that macrophages represent the crucial effectors of the rAsp f3-based vaccine.
Keywords: Asp f3, aspergillosis, Aspergillus fumigatus, corticosteroid immunosuppression, macrophages,
neutropenia, neutrophils, vaccine
INTRODUCTION
The filamentous fungus is widely present in the environment and
is responsible for most fatal cases of invasive aspergillosis (IA)
that occur in patients with hematologic malignancies, especially
recipients of hematopoietic cell transplantation (HCT), a com-
mon treatment for leukemia, lymphoma, and other hematological
malignancies. Patients at highest risk of developing IA are those
who experience prolonged neutropenia and those who undergo
prolonged immunosuppressive treatments, for example to control
graft-vs.-host disease after HCT (Marr et al., 2002; Cordonnier
et al., 2006; Segal et al., 2007; Baddley et al., 2010; Kontoyiannis
et al., 2010).
In an immunocompetent host, macrophages and neutrophils
mediate the innate immune response against fungal pathogens.
Previously, macrophages were postulated as the first line of
defense against conidia, and neutrophils were recognized as the
key cell population that provides protection against hyphae and
swollen conidia through oxidative and non-oxidative mechanisms
(Schaffner et al., 1982; Diamond, 1983; Diamond et al., 1983;
Roilides et al., 1993; Feldmesser, 2006; Park and Mehrad, 2009;
Hasenberg et al., 2011). However, more recent studies have demon-
strated that neutrophils provide anti-conidial defense at early time
points following A. fumigatus infection. For example, A. fumi-
gatus infected mice in which neutrophils are depleted before or
within 3 h after fungal infection exhibit a high mortality rate. In
contrast, neutrophil depletion at later time points post-infection
is associated with survival (Mircescu et al., 2009). Similarly, a
comparison of different immunosuppressive regimens showed
that neutrophil recruitment, rather than recruitment of alveolar
macrophages, is essential for early host defense against aspergillosis
(Ibrahim-Granet et al., 2010).
An efficient and safe strategy to protect immunosuppressed
patients from fungal infections could involve specific reconstitu-
tion of the immune response with an antifungal vaccine. There-
fore, in recent years, several approaches have been taken to develop
an A. fumigatus vaccine. Immunizations with the recombinant
Asp f3-protein and truncated portions thereof protected cortisone
acetate (CA)-immunosuppressed mice against pulmonary IA (Ito
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et al., 2006). Moreover, the A. fumigatus cell wall glucanase Crf1
protected mice against both A. fumigatus and Candida albicans
(Stuehler et al., 2011). Furthermore, a protein designated Asp f16,
when combined with unmethylated CpG, was able to induce Th1
priming and resistance to the fungus (Bozza et al., 2002). How-
ever, it is controversial whether Asp f16 actually exists (Bowyer
and Denning, 2007) or instead is a splice form of the crf1 gene,
together with the sequence-related vaccine candidates Asp f9 and
Crf1 (Schutte et al., 2009). In another approach, it was shown that
heat-killed Saccharomyces can protect immunosuppressed mice
against systemic aspergillosis (Liu et al., 2011), and immunizations
with Laminaria digitata β-glucan proved to be protective against
C. albicans and systemic aspergillosis (Torosantucci et al., 2005,
2009). Despite these promising research results, no aspergillosis
vaccine has made it into clinical use thus far. The difficulty lies in
the question on how to vaccine-protect severely immunocompro-
mised individuals. Because patients who receive HCT have initially
low counts of T and B cells, it is usually not advisable to vac-
cinate HCT-receiving patients immediately after transplantation
(Ljungman et al., 2009). For example, the guidelines for prevent-
ing infectious complications among HCT recipients advise waiting
6–12 months post-HCT to deliver the first bacterial vaccines, and
2 years post-HCT for attenuated viral vaccines (Tomblyn et al.,
2009). Detailed knowledge about the mediators and effectors of
an antifungal vaccine’s mechanism is required to devise a safe and
effective immunization strategy for HCT recipients.
CD4+ T cells are recognized as key mediators of the protective
immune response for the control of IA (Beck et al., 2006; Tram-
sen et al., 2009; Chaudhary et al., 2010; Diaz-Arevalo et al., 2011).
Functionally active CD4+ T cells in combination with antigen
presenting cells contributed to enhance the neutrophil effector
function that caused hyphal damage in an in vitro study with
A. fumigatus (Beck et al., 2006). Likewise, stimulation of poly-
morphonuclear leukocytes (PMNs) with Th1 cytokines allowed
hyphal damage in the presence of hydrocortisone (Roilides et al.,
1993) and TNF-alpha augments the ability of PMNs to damage
Aspergillus hyphae, and increases macrophage phagocytic activity
against conidia (Roilides et al., 1998).
In the studies described herein, we studied the role of innate
effector cells in a pulmonary IA model with rAsp f3-vaccinated
mice. We present novel data on both antibody-induced neutrope-
nia and corticosteroid-induced immunosuppression, as well as
their effects on susceptibility to A. fumigatus infection, protec-
tion conferred by the rAsp f3-vaccine, the role of neutrophils
in vaccine derived protection, and the resulting differences in IA
pathophysiology under the two conditions.
MATERIALS AND METHODS
ANIMALS, STRAINS, AND REAGENTS
Female CF-1 mice (20 g, 6–8 weeks old) were purchased from
Charles River Laboratory and housed in a biosafety level 2 con-
trol facility. The mice were cared in accordance with animal care
regulation and use protocols approved by the City of Hope Insti-
tutional Animal Care and Use Committee. Animal numbers (n,
between 8 and 26) per group are indicated in the figure captions.
Aspergillus fumigatus strain AFCOH1 (Ito et al., 2006; Ito et al.,
2009; Diaz-Arevalo et al., 2011) was used in all experiments and
was cultured on potato dextrose agar (BD/Difco,Aspergillus fumi-
gatusFranklin Lakes, NJ, USA) for 7 days at 37˚C. Resting conidia
were harvested by rinsing from the cultured fungus, and resus-
pended in Dulbecco’s phosphate-buffered saline without calcium
and magnesium (DPBS,Mediatech, Inc.,Manassas,VA,USA) prior
to infection. Conidia were quantified with a Countess Automated
Cell Counter (Invitrogen, Eugene, OR, USA), and their viability
was measured by colony forming unit assay.
VACCINATION, IMMUNOSUPPRESSION, AND A. FUMIGATUS
CHALLENGE
CF-1 mice were immunized twice, once per day on days 0 and
14, with subcutaneous injections of N-terminal truncated rAsp
f3-based vaccine (15µg) suspended in TiterMax (TiterMax, Inc.,
Norcross, GA, USA) as previously described (Ito et al., 2006). For
neutrophil depletion assays, mice were injected with the vaccine
a third time on day 60. As controls, mock vaccinated mice were
injected with PBS plus TiterMax. Prior to infection, one of the
following immunosuppression treatments was applied.
Cortisone acetate treatment
Cortisone acetate (CA) immunosuppression was performed as
described previously (Diaz-Arevalo et al., 2011). Briefly, 5 weeks
after the second vaccination the mice received daily injections of
CA (2.5 mg/mouse, TCI America, Portland, OR, USA) suspended
in methylcellulose (0.5%, Sigma, Aldrich, St. Louis, MO, USA) and
Tween 80 (0.1%) for 10 days prior to fungal infection.
In vivo depletion of neutrophils
For neutrophil depletion, vaccinated mice received intraperitoneal
injection of anti-GR1-specific monoclonal antibody RB6-8C5
(100µg, Bio X Cell, West Lebanon, NH, USA) or, as a control,
rat IgG (Sigma, Aldrich, St. Louis, MO, USA), 1 day before and
after fungal challenge. Neutrophil depletion was monitored by
flow cytometric analysis of tail blood (50µl) from two randomly
selected mice from each group. Neutrophils were stained with allo-
phycocyanin (APC)-labeled anti-GR1 (RB6-8C5), or APC-labeled
anti-Ly6G (1A8), and PerCP-Cy5.5-conjugated anti-Ly6C anti-
body (eBioscience, Inc., San Diego, CA, USA). T cells were label
with PE anti-CD3 conjugated and FITC labeled anti-CD8. Data
were analyzed using FlowJo 7.5 (Tree Star, Inc.,Ashland, OR, USA),
and paired t test was used for statistical analysis.
In addition, one group of mice was immunosuppressed with
CA for 10 days, after which mice received the anti-GR1 anti-
body two and 1 day before infection as described above. Control
mice were immunosuppressed with CA followed by injection of
non-specific rat IgG antibody at identical time points.
To prevent bacterial infection, mice were maintained on acidi-
fied water containing sulfamethoxazole (0.8 mg/ml) and trimetho-
prim (0.16 mg/ml; Hi-Tech Pharmacal Co., Inc., Amityville, NY,
USA) during the immunosuppression and infection period.
Prior to intranasal (i.n.) inoculation with A. fumigatus conidia,
mice were anesthetized by subcutaneous injection of ketamine-
xylazine. Mice were then intranasally challenged with 3–30 million
viable conidia (VC) in DPBS (30µl). Infected mice were observed
every 2 h during the day, and their weight and body tempera-
ture were monitored twice per day for 4–12 days after infection,
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FIGURE 1 | Comparison of CA-immunosuppression and neutrophil
depletion and their effects on IA survival. (A) Kaplan–Meier survival
plots of CF-1 mice i.n. infected with three million viable A. fumigatus
conidia. Curves show CA-immunosuppressed mice with non-specific rat
IgG as controls (Rat IgG/CA, triangles, n=9), CA-immunosuppressed mice
with anti-GR1 antibody (anti-GR1/CA, open triangles, n=10),
neutrophil-depleted mice (anti-GR1, circles, n=12), and
non-immunosuppressed mice with non-specific rat IgG (Rat IgG, squares,
n=12). (B,C) FACS analysis of Ly6C+ GR1+ neutrophils in tail blood from
control mice (left panels, Rat IgG) and neutrophil-depleted mice (right
panels, anti-GR1; (B)] without CA-immunosuppression and (C) with
CA-immunosuppression. The circle marks the population of neutrophils
coated with the unlabelled anti-GR1 antibody. (D) Binding of anti-rat
antibody to anti-GR1 IgG-coated neutrophils in CA-immunosuppressed
mice from the circled population in (C) (right panel, anti-GR1) compared to
the isotype control (left panel, Rat IgG). (E) Effect of anti-GR1 antibody on
the depletion of monocytes, CD8+ T cells and neutrophils in mouse blood,
n=3; ∗statistically significant, p<0.05.
depending on the type of experiment (Ito et al., 2006; Diaz-Arevalo
et al., 2011). Survival data was plotted by the Kaplan–Meier
method and statistical analyses performed using Fisher’s exact test
and Graph Pad Prism software (GraphPad Software, Inc., La Jolla,
CA, USA).
HISTOPATHOLOGY AND IMMUNOHISTOCHEMISTRY
Vaccinated mice that survived were euthanized 5 days afterA. fumi-
gatus infection and their lungs collected and immediately fixed
in 10% formalin and embedded in paraffin. The lungs of non-
surviving mice were collected from four mice at the time of death.
Lung sections were stained with hematoxylin and eosin (HE), and
Gomori methenamine silver staining was used to stain hyphal
mycelium and remaining conidia.
Immunohistochemistry was performed using anti-CD3
(Dako Inc., Carpinteria, CA, USA), anti-GR1, and anti-F4/80
(eBioscience, Inc., San Diego, CA, USA) primary antibodies and
horseradish peroxidase (HRP) conjugated anti-rat IgG (Alpha
Diagnostic Intl. Inc., San Antonio, TX, USA) as the secondary
antibody. Imaging was performed on an Olympus AX70 model U-
MPH microscope (Tokyo, Japan) with a QImaging RETIGA EXi
camera. Data were acquired with Image ProPlus v5.1 software.
RESULTS
CORTISONE ACETATE IMMUNOSUPPRESSION RENDERS MICE MORE
SUSCEPTIBLE TO PULMONARY ASPERGILLOSIS THAN NEUTROPHIL
DEPLETION
We first assessed the susceptibility of mice to invasive pul-
monary aspergillosis after induction of either CA-induced
immunosuppression or antibody-mediated neutrophil deple-
tion. When challenged with three million VC, only 10–20% of
CA-immunosuppressed mice survived (Figure 1A, curve Rat
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FIGURE 2 |The rAsp f3-based vaccine protects neutrophil-depleted mice.
(A) Timeline of immunization, neutrophil depletion and A. fumigatus
challenge. (B) FACS analysis of Ly6C+/GR1+ neutrophils in tail blood of rAsp
f3-vaccinated mice after anti-GR1 antibody-mediated neutrophil depletion (left
panel) compared to that of CA-immunosuppressed mice (right panel). (C)
Kaplan–Meier survival curves of neutrophil-depleted mice challenged with 30
million viable conidia (VC) after mock vaccination with buffer and TiterMax
(PBS-TM, triangles, n=17) or rAsp f3-vaccine (rAsp f3, circles, n=12), and
non-immunosuppressed, non-vaccinated controls (Control, diamond, n= 12).
(D) Survival of CA-immunosuppressed mice challenged with 30 million VC
after rAsp f3-vaccination (rAsp f3, squares, n=12) or mock vaccination
(PBS-TM, triangles, n=5). (E) CA-immunosuppressed mice challenged with
three million VC, rAsp f3-vaccinated (circles, n=28), or mock vaccinated
(squares, n=26).
IgG/CA). In contrast,∼67% of the neutrophil-depleted mice sur-
vived the infection (Figure 1A, curve anti-GR1). However, at
an infectious dose of 30 million VC, the survival of neutrophil-
depleted mice was comparable to that of CA-immunosuppressed
mice that received only three million spores (6% survival vs.
10–20% survival, respectively; Figure 2C vs. Figure 1A). There-
fore we concluded that, CA treatment made the mice more
susceptible to A. fumigatus infection than neutrophil depletion.
Because we depleted neutrophils with a rat anti-GR1 antibody,
we treated CA-immunosuppressed mice with a non-specific rat
IgG as a control, which had no significant effect on survival.
In addition, the control group that received only rat IgG and
no further immunosuppression survived the infection entirely
(Figure 1A). We also combined CA-immunosuppression with
anti-GR1-mediated neutrophil depletion, but this did not further
increase the susceptibility of the mice to A. fumigatus infec-
tion (Figure 1A). To confirm that neutrophils were depleted,
we monitored neutrophil counts by FACS analysis using Ly6C
and GR1 as markers. Twenty-four hours after injection of anti-
GR1 antibody, neutrophil counts were reduced to 0.033% of
normal levels (Figure 1B). Treatment with non-specific rat
IgG did not change the neutrophil population of the mice
(Figure 1B).
When we attempted to deplete neutrophils in CA-
immunosuppressed mice, we observed that a population of neu-
trophils was still present after treatment, but their staining with an
APC-labeled anti-GR1 antibody had shifted to lower intensities
in the FACS analysis (Figure 1C). Furthermore, the circulating
neutrophils were still coated with the anti-GR1 antibody that
was given to induce their depletion (Figure 1D). Others have
observed a similar shift in the population of labeled neutrophils
when attempting to antibody-deplete neutrophils after reduc-
tion of peritoneal macrophage numbers with Clodronate lipo-
somes (Mircescu et al., 2009). No significant reduction of mono-
cytes and CD8+ cells was observed after neutrophil depletion
(Figure 1E).
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FIGURE 3 | Histopathologies of pulmonary IA. Micrographs of Gomori
silver (A,B,E,F) and hematoxylin and eosin (C,D,G,H) staining of lung
tissues from rAsp f3-vaccinated survivors (A,C,E,G) and mock vaccinated
non-survivors (B,D,F,H) from neutrophil-depleted mice (A–D), and
CA-immunosuppressed mice (E–H). Scale bars are 50µm. The insert is a
4× magnification of the underlying micrograph.
Asp f3-VACCINE PROTECTION IS NOT ABOLISHED AFTER NEUTROPHIL
DEPLETION
To study the role of neutrophils in rAsp f3-vaccinated mice, we
depleted neutrophils with anti-GR1 antibody (Figure 2A). Admin-
istration of the antibody led to systemic depletion of neutrophils,
down to 0.004% of the population, while neutrophils composed
1.26% of the population in mice that were immunosuppressed
with CA (Figure 2B). Neutrophil depletion partially affected the
survival of vaccinated mice in that 40% of the mice remained pro-
tected after A. fumigatus infection. In contrast, non-immunized,
neutrophil-depleted mice were highly susceptible to the infection
(Figure 2C). Although the observed difference in survival lacks
strict statistical significance (p= 0.056) a trend of partial vaccine
protection of neutrophil-depleted mice is apparent.
As a control, we immunosuppressed rAsp f3-vaccinated mice
with CA and then challenged them with 30 million conidia. Only
20% of these mice survived A. fumigatus infection, and no sta-
tistical difference in survival (p= 1) was observed between rAsp
f3-immunized mice and non-vaccinated mice (Figure 2D). We
attribute the high mortality of vaccinated mice to the very high
number of conidia (30 M) used for challenge. Consistent with our
previous observations (Ito et al., 2006; Diaz-Arevalo et al., 2011),
vaccinated, CA-immunosuppressed mice challenged with three
million conidia had significantly enhanced survival (p= 0.009)
over that of non-vaccinated mice (Figure 2E).
DIFFERENCES IN PULMONARY PATHOLOGY BETWEEN
CA-IMMUNOSUPPRESSED AND NEUTROPHIL-DEPLETED MICE
Histological analysis using Gomori methenamine silver stain-
ing of the lungs of non-immunized, neutrophil-depleted mice
showed extensive hyphal tissue invasion (Figure 3A vs. Figure 3B)
characterized by hemorrhagic foci, with inflammatory infiltrates,
necrotic tissue, and edema (Figure 3C vs. Figure 3D). The
fungi were located in a few patchy areas in the lungs, and the
mycelium contained multiply branched, densely grown hyphae
(Figure 3B). In contrast, CA-immunosuppressed, non-vaccinated
mice, had hyphal elements throughout the entire lung, but
the mycelium consisted of only short hyphal fragments with
very few branches (Figure 3F). In contrast, lungs of rAsp f3-
vaccinated CA-immunosuppressed (Figure 3E) and neutrophil-
depleted mice (Figure 3A) had no hyphae and only a small number
of non-germinated conidia were present in the lung parenchyma.
Lungs of neutrophil-depleted, rAsp f3-vaccinated mice showed
only mild infiltration of macrophages and CD3+ T cells
in the peribronchial tissue (Figures 4A–C). Vaccinated CA-
immunosuppressed mice had a similar type of peribronchial infil-
trate that included neutrophils (Figures 4G–I). The infiltrate of
immune cells in neutrophil-depleted, non-immunized mice was
characterized by presence of CD3+ T cells and absence of neu-
trophils and alveolar macrophages (Figures 4D–F). The lungs of
non-vaccinated, CA-immunosuppressed mice exhibited extensive
infiltration of PMNs and CD3+ T cells, but almost completely
lacked alveolar macrophages (Figures 4J–L), and exhibited edema
and focal hemorrhage (Figure 3H).
DISCUSSION
THE ROLE OF NEUTROPHILS IN ANTIFUNGAL PROTECTION
In the current study, we demonstrated that rAsp f3-vaccination
shows a protective trend in neutrophil-depleted mice (40% sur-
vival) challenged with pulmonary A. fumigatus infection. Consis-
tent, with previous work by others (Mircescu et al., 2009; Ibrahim-
Granet et al., 2010), our data suggest that neutrophils are essential
for the innate immune protection of immunocompetent animals
againstA. fumigatus. Furthermore, the protective effect of the vac-
cine can only be observed in immunosuppressed mice, as it has
not been possible to induce fatal pulmonary A. fumigatus infec-
tions in immunocompetent mice. However, neutrophils do not
appear to be the key effector cells that provide vaccine protection
against A. fumigatus, because neutrophil depletion did not abolish
the protective vaccine effect entirely.
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FIGURE 4 | Immunohistochemical characterization of the inflammatory
infiltrates in lungs of mice with IA. Micrographs of A. fumigatus infected
lungs of rAsp f3-vaccinated survivors [VS (A–C,G–I)] and mock vaccinated
non-survivors [NS (D–F,J–L)] from neutrophil-depleted (A–F) or
CA-immunosuppressed mice (G–L). T cells were stained with anti-CD3
antibody (A,D,G,J), neutrophils with anti-GR1 (RB6-8C5) antibody (B,E,H,K)
and alveolar macrophages with anti-F4/80 antibody (C,F,I,L), followed by
anti-rat IgG-HRP antibody and 3,3′-diaminobenzidine staining (brown). Lungs
of VS were collected 5 days after A. fumigatus infection. Scale bars are 50µm.
The insert is a 4×magnification of the underlying micrograph.
A secondary auxiliary role in antifungal protection was pre-
viously attributed to neutrophils in an in vitro study in which
specific T cells in combination with antigen presenting cells
and neutrophils enhanced the damage to cultured A. fumiga-
tus hyphae (Beck et al., 2006). It must be pointed out that the
immune system of immunosuppressed mice can be overwhelmed
when the infectious dose is sufficiently large, regardless of vac-
cination status. However, the markedly higher susceptibility of
CA-immunosuppressed mice as compared to that of neutrophil-
depleted mice indicates that macrophages contribute substantially
to innate antifungal protection, as CA is known reduce the killing
potential of macrophages (Schaffner, 1985; Ibrahim-Granet et al.,
2003; Philippe et al., 2003), and it elicits a broad effect on the
immune system by reducing the numbers of immune cells and
cytokine signaling (Almawi and Melemedjian, 2002).
ANTIBODY-MEDIATED NEUTROPHIL DEPLETION
The RB6-8C5 antibody is known to bind to the neutrophil cell sur-
face antigens Ly6G and Ly6C, the latter with lower affinity (Flem-
ing et al., 1993). Because Ly6C is not only present on neutrophils,
but also on monocytes (Henderson et al., 2003), plasmacytoid den-
dritic cells (Nakano et al., 2001), and a subpopulation of CD8+
cells (Matsuzaki et al., 2003), we also analyzed PBMCs for a reduc-
tion of monocytes and CD8+ cells, but found it not to be statically
significant (Figure 1E) and consistent with previous observations
(Mircescu et al., 2009). Although the more specific anti-Ly6G anti-
body 1A8 can alternatively be used to deplete neutrophils (Daley
et al., 2008), we chose the RB5-8C5 antibody, which is readily avail-
able, has been well characterized, and used extensively to study the
role of neutrophils in A. fumigatus infection (Mehrad et al., 1999;
Mircescu et al., 2009; Ibrahim-Granet et al., 2010).
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HISTOPATHOLOGY OF rAsp f3-VACCINATED AND NON-IMMUNIZED
ANIMALS
The IA histopathology of CA-immunosuppressed mice was
markedly different from that of neutrophil-depleted mice. The
absence of a robust macrophage response in the non-immunized
neutrophil-depleted mice may explain why A. fumigatus was able
to invade the lungs and grow into dense patches with highly
branched hyphal mycelium. Furthermore, the presence of a strong
neutrophil infiltrate in CA-immunosuppressed mice, may explain
why the hyphal elements appeared much shorter, because they
may be constantly damaged by neutrophils, although this damage
is not sufficient for fungal clearance. This observation is consis-
tent with the suggestion that steroid-induced immunosuppression
may lead to an inflammatory response that is destructive to lung
tissue (Balloy et al., 2005; Stephens-Romero et al., 2005). How-
ever, neutrophil-depleted mice were not protected from IA either,
and their inflammatory infiltrate at the time of death consisted
mainly of CD3+ T cells and largely lacked macrophages. It is
possible that, due to the larger infectious inoculum used, the
macrophages were simply overwhelmed or their resident popu-
lation was exhausted. Interestingly, the CD3+ T cell infiltrate was
unable to recruit further macrophages, whereas in mice immu-
nized with the rAsp f3-vaccine, T cell recruitment of macrophages
to the point of infection appears to be associated with success-
ful clearance of the fungal pathogen (Figures 3 and 4). Our
observation does not exclude the possibility that other cell pop-
ulations such as CD8+ T cells and natural killer (NK) cells could
contribute to vaccine based antifungal protection; however, the
selective depletion of CD4+ cells readily abolishes rAsp f3-based
vaccine protection (Diaz-Arevalo et al., 2011). The involvement of
NK cells in other type of vaccinations was demonstrated recently;
for example the production of IL-2 by antigen specific CD4+ T
cells enhanced NK activation after vaccination either with Plas-
modium falciparum (Horowitz et al., 2010b; McCall et al., 2010),
rabies virus (Horowitz et al., 2010a), or simian immunodeficiency
virus (Vargas-Inchaustegui et al., 2012). Therefore, although the
effector role of macrophages appears to be very likely, further
investigation will be required to understand if CD8+ T or NK cells
participate in the mechanism of the rAsp f3-based A. fumigatus
vaccine.
CONCLUSION
Our results suggest CA-immunosuppressed mice are much more
susceptible to A. fumigatus infection than neutrophil-depleted
mice. Neutrophils, although important for innate antifungal pro-
tection of immunocompetent hosts, are not the relevant effec-
tors for rAsp f3-vaccine derived protection in immunosuppressed
hosts. Considering our immunohistochemical observations, it
appears to be far more likely that macrophages (or possibly other
cell types) are the crucial effectors of the rAsp f3-based vaccine.
Further research will be required to refine this model.
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